{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:45:11Z","timestamp":1784623511089,"version":"3.55.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Malignant atrophic papulosis\/K\u00f6hlmeier\u2013Degos disease was first described in 1941 by K\u00f6hlmeier in an anecdotal case report that described a young man who presented with extensive multiple intestinal perforations and a papular skin rash. K\u00f6hlmeier\u2013Degos disease represents a unique vasculopathy targeting both the microvasculature and the arterial system. One of its most characteristic features is reflected by the discrete multifocal depressed porcelain lesions involving the skin and gastrointestinal tract. The pathological findings are striking and can be broadly categorized into those that are vascular in nature versus extravascular matrix production in the context of extensive extravascular hyaluronic acid and collagen deposition. A dynamic evolutionary morphology is observed not only clinically but also histologically. The microvascular alterations are particularly evident in the skin and are characterized by endothelial cell necrosis with subsequent endothelial cell detachment accompanied by intraluminal fibrin deposition, defining a thrombogenic microangiopathy that in later stage lesions is typically pauci-inflammatory. The arterial lesions are very distinctive and include significant neointimal proliferation with vascular luminal occlusion by amorphous plugs of collagen intimately admixed with platelets. Pathogenetically enhanced type I interferon signaling and endothelial cell injury mediated by the membranolytic attack complex (ie, C5b-9) are key in the evolution of the thrombotic microvascular and obliterative fibrosing arteriopathic changes. We describe a case of K\u00f6hlmeier\u2013Degos disease that developed in the setting of tumor necrosis factor (TNF)-alpha inhibitor therapy with the drug golimumab. The clinical features, light microscopic findings, and a pathophysiologic paradigm based on the critical role of TNF-alpha in controlling the type I interferon response are discussed.<\/jats:p>","DOI":"10.1097\/dad.0000000000002765","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T13:00:43Z","timestamp":1723813243000},"page":"605-610","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Tumor necrosis factor ALPHA Inhibitor Associated K\u00f6hlmeier\u2013Degos Disease as a Novel Iatrogenic Paradigm That Underscores Excessive Type I Interferon in Its Pathogenesis"],"prefix":"10.1097","volume":"46","author":[{"given":"Cynthia M.","family":"Magro","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Sanders","sequence":"additional","affiliation":[{"name":"Sanders Dermatology, New City, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"key":"R1-20250616","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/BF01828450","article-title":"Multiple skin necrosis in thromboangiitis obliterans","volume":"181","author":"K\u00f6hlmeier","year":"1941","journal-title":"Archive Dermatol Syphilis"},{"key":"R2-20250616","first-page":"148","article-title":"Dermatite papulosquameuse atrophiante","volume":"49","author":"Degos","year":"1942","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"R3-20250616","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1172-8-10","article-title":"Malignant atrophic papulosis (K\u00f6hlmeier-Degos disease)\u2014a review","volume":"8","author":"Theodoridis","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"R4-20250616","first-page":"10","article-title":"Presentation de moulage. Ulerytheme porcelaine en gouttes","volume":"55","author":"Tzanck","year":"1948","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"R5-20250616","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1309\/AJCP66QIMFARLZKI","article-title":"Degos disease: a C5b-9\/interferon-\u03b1\u2013mediated endotheliopathy syndrome","volume":"135","author":"Magro","year":"2011","journal-title":"Am J Clin Pathol."},{"key":"R6-20250616","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1750-1172-8-185","article-title":"The effects of Eculizumab on the pathology of malignant atrophic papulosis","volume":"8","author":"Magro","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"R7-20250616","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2230.2007.02497.x","article-title":"Malignant atrophic papulosis","volume":"32","author":"Scheinfeld","year":"2007","journal-title":"Clin Exp Dermatol."},{"key":"R8-20250616","doi-asserted-by":"crossref","first-page":"151943","DOI":"10.1016\/j.anndiagpath.2022.151943","article-title":"Exploring the pathophysiologic basis of constrictive pericarditis of Kohlmeier Degos disease: a case series and review of the literature","volume":"59","author":"Magro","year":"2022","journal-title":"Ann Diagn Pathol."},{"key":"R9-20250616","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1056\/NEJM196701262760402","article-title":"Progressive arterial occlusive disease (K\u00f6hlmeier-Degos). A frequently fatal cutaneosystemic disorder","volume":"276","author":"Strole","year":"1967","journal-title":"N Engl J Med."},{"key":"R10-20250616","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1600-0560.2009.01443.x","article-title":"The phenotypic profile of dermatomyositis and lupus erythematosus: a comparative analysis","volume":"37","author":"Magro","year":"2010","journal-title":"J Cutan Pathol."},{"key":"R11-20250616","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/DAD.0000000000000234","article-title":"Role of the skin biopsy in the diagnosis of atypical hemolytic uremic syndrome","volume":"37","author":"Magro","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"R12-20250616","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.humpath.2020.10.002","article-title":"Docked severe acute respiratory syndrome coronavirus 2 proteins within the cutaneous and subcutaneous microvasculature and their role in the pathogenesis of severe coronavirus disease 2019","volume":"106","author":"Magro","year":"2020","journal-title":"Hum Pathol."},{"key":"R13-20250616","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.42662","article-title":"Endothelial response to type I interferon contributes to vasculopathy and fibrosis and predicts disease progression of systemic sclerosis","volume":"76","author":"Yin","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"R14-20250616","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3324\/haematol.2020.255612","article-title":"Human platelets are a source of collagen I","volume":"106","author":"Kyselova","year":"2021","journal-title":"Haematologica"},{"key":"R15-20250616","first-page":"101","article-title":"Lesions resembling malignant atrophic papulosis in a patient with progressive systemic sclerosis","volume":"75","author":"Liu","year":"2005","journal-title":"Cutis"},{"key":"R16-20250616","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2310\/7750.2011.10035","article-title":"Degos disease with dermatomyositis-like phenomenon: a diagnostic dilemma and a therapeutic challenge","volume":"15","author":"Gupta","year":"2011","journal-title":"J Cutan Med Surg."},{"key":"R17-20250616","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/ijd.13629","article-title":"Systemic lupus erythematosus with Degos disease: role of dermatoscopy in diagnosis","volume":"56","author":"Vinay","year":"2017","journal-title":"Int J Dermatol."},{"key":"R18-20250616","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1529-8019.2008.01216.x","article-title":"New biologics for psoriasis and psoriatic arthritis","volume":"22","author":"Rozenblit","year":"2009","journal-title":"Dermatol Ther"},{"key":"R19-20250616","first-page":"e42791","article-title":"Paradoxical tumor necrosis factor-alpha (TNF-\u03b1) inhibitor-induced psoriasis: a systematic review of pathogenesis, clinical presentation, and treatment","volume":"15","author":"Chokshi","year":"2023","journal-title":"Cureus"},{"key":"R20-20250616","doi-asserted-by":"crossref","first-page":"8187","DOI":"10.3390\/ijms24098187","article-title":"Focus on anti-tumour necrosis factor (TNF)-\u03b1-Related autoimmune diseases","volume":"24","author":"Lopetuso","year":"2023","journal-title":"Int J Mol Sci."},{"key":"R21-20250616","doi-asserted-by":"crossref","first-page":"103332","DOI":"10.1016\/j.autrev.2023.103332","article-title":"Tumor necrosis factor-\u03b1 inhibitor-related autoimmune disorders","volume":"22","author":"De Stefano","year":"2023","journal-title":"Autoimmun Rev."},{"key":"R22-20250616","first-page":"88","article-title":"Paradoxical reactions to biologicals in chronic inflammatory systemic diseases","volume":"119","author":"Kremenevski","year":"2022","journal-title":"Dtsch Arztebl Int."},{"key":"R23-20250616","first-page":"e15986","article-title":"A case of adalimumab-induced granulomatous interstitial nephritis","volume":"13","author":"Plant","year":"2021","journal-title":"Cureus"},{"key":"R24-20250616","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3389\/fimmu.2018.00444","article-title":"Tumor necrosis factor \u03b1 and regulatory T cells in oncoimmunology","volume":"9","author":"Salomon","year":"2018","journal-title":"Front Immunol."},{"key":"R25-20250616","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41467-017-02466-4","article-title":"TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis","volume":"9","author":"Conrad","year":"2018","journal-title":"Nat Commun."},{"key":"R26-20250616","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.clindermatol.2021.07.001","article-title":"The skin as a critical window in unveiling the pathophysiologic principles of COVID-19","volume":"39","author":"Magro","year":"2021","journal-title":"Clin Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:03:37Z","timestamp":1750097017000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002765","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}